3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
23
Sarcoma
18
Neoplasms
8
Neoplasm Metastasis
8
Breast Neoplasms
8
Ovarian Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Liposarcoma
5
Leiomyosarcoma
5
Hemangiosarcoma
5
Sarcoma, Synovial
4
Neurofibrosarcoma
4
Lung Neoplasms
4
Kidney Neoplasms
4
Histiocytoma, Malignant Fibrous
4
Urinary Bladder Neoplasms
3
Recurrence
3
Prostatic Neoplasms
3
Glioblastoma
3
Thyroid Carcinoma, Anaplastic
2
Small Cell Lung Carcinoma
2
Sarcoma, Alveolar Soft Part
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Melanoma
2
Gliosarcoma
2
Fibrosarcoma
2
Dermatofibrosarcoma
2
Clear-cell metastatic renal cell carcinoma
2
Interventions
X-Rays
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Phantoms, Imaging
5
Vincristine
4
Nuclear Medicine Department, Hospital
4
Doxorubicin
4
Dactinomycin
4
Radiotherapy
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Radiotherapy, Conformal
2
Radiation
2
LY3023414
2
Etoposide
2
Cyclophosphamide
2
Carboplatin
2
thymoglobulin
1
sargramostim
1
pembrolizumab
1
lorvotuzumab mertansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Wilms Tumor
×
pazopanib
×
Clear all
No trials found.